{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:43:03Z","timestamp":1769733783451,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,29]]},"DOI":"10.7759\/cureus.24584","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T10:09:12Z","timestamp":1651226952000},"source":"Crossref","is-referenced-by-count":1,"title":["Hereditary Pheochromocytoma With a Mutation in the Succinate Dehydrogenase Subunit A Gene"],"prefix":"10.7759","author":[{"given":"Gowri","family":"Karuppasamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer A","family":"Farooqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadia","family":"Sajid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elhadi","family":"Elouzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03256.x","article-title":"123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation","volume":"69","author":"Bhatia KS","year":"2008","unstructured":"Bhatia KS, Ismail MM, Sahdev A, et al.. 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation. Clin Endocrinol (Oxf). 2008, 69:181-8. 10.1111\/j.1365-2265.2008.03256.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders JW","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, et al.. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014, 99:1915-42. 10.1210\/jc.2014-1498","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2014.188","article-title":"Paraganglioma and phaeochromocytoma: from genetics to personalized medicine","volume":"11","author":"Favier J","year":"2015","unstructured":"Favier J, Amar L, Gimenez-Roqueplo AP. Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol. 2015, 11:101-11. 10.1038\/nrendo.2014.188","journal-title":"Nat Rev Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12071","article-title":"Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma","volume":"78","author":"Galan SR","year":"2013","unstructured":"Galan SR, Kann PH. Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma. Clin Endocrinol (Oxf). 2013, 78:165-75. 10.1111\/cen.12071","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2012.01.009","article-title":"Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background","volume":"205","author":"Fishbein L","year":"2012","unstructured":"Fishbein L, Nathanson KL. Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background. Cancer Genet. 2012, 205:1-11. 10.1016\/j.cancergen.2012.01.009","journal-title":"Cancer Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/his.13402","article-title":"Pathology and genetics of phaeochromocytoma and paraganglioma","volume":"72","author":"Turchini J","year":"2018","unstructured":"Turchini J, Cheung VK, Tischler AS, De Krijger RR, Gill AJ. Pathology and genetics of phaeochromocytoma and paraganglioma. Histopathology. 2018, 72:97-105. 10.1111\/his.13402","journal-title":"Histopathology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma","volume":"19","author":"Burnichon N","year":"2010","unstructured":"Burnichon N, Bri\u00e8re JJ, Lib\u00e9 R, et al.. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet. 2010, 19:3011-20. 10.1093\/hmg\/ddq206","journal-title":"Hum Mol Genet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01762","article-title":"Clinical aspects of SDHA-Related pheochromocytoma and paraganglioma: a nationwide study","volume":"103","author":"van der Tuin K","year":"20181","unstructured":"van der Tuin K, Mensenkamp AR, Tops CMJ, et al.. Clinical aspects of SDHA-Related pheochromocytoma and paraganglioma: a nationwide study. J Clin Endocrinol Metab. 20181, 103:438-45. 10.1210\/jc.2017-01762","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/js.2018-00120","article-title":"Pathogenicity and penetrance of germline SDHA variants in pheochromocytoma and paraganglioma (PPGL)","volume":"2","author":"Maniam P","year":"2018","unstructured":"Maniam P, Zhou K, Lonergan M, Berg JN, Goudie DR, Newey PJ. Pathogenicity and penetrance of germline SDHA variants in pheochromocytoma and paraganglioma (PPGL). J Endocr Soc. 2018, 2:806-16. 10.1210\/js.2018-00120","journal-title":"J Endocr Soc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0030","article-title":"SDHA mutated paragangliomas may be at high risk of metastasis","volume":"24","author":"Tufton N","year":"2017","unstructured":"Tufton N, Ghelani R, Srirangalingam U, et al.. SDHA mutated paragangliomas may be at high risk of metastasis. Endocr Relat Cancer. 2017, 24:L43-9. 10.1530\/ERC-17-0030","journal-title":"Endocr Relat Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1862","article-title":"Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes","volume":"91","author":"Benn DE","year":"2006","unstructured":"Benn DE, Gimenez-Roqueplo AP, Reilly JR, et al.. Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes. J Clin Endocrinol Metab. 2006, 91:827-36. 10.1210\/jc.2005-1862","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0206","article-title":"A case of a metastatic SDHA mutated paraganglioma re-presenting twenty-three years after initial surgery","volume":"24","author":"Casey RT","year":"2017","unstructured":"Casey RT, Challis BG, Marker A, et al.. A case of a metastatic SDHA mutated paraganglioma re-presenting twenty-three years after initial surgery. Endocr Relat Cancer. 2017, 24:L69-71. 10.1530\/ERC-17-0206","journal-title":"Endocr Relat Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0223","article-title":"Clinical characterization of the pheochromocytoma and paraganglioma susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for gene-informed prevention","volume":"3","author":"Bausch B","year":"2017","unstructured":"Bausch B, Schiavi F, Ni Y, et al.. Clinical characterization of the pheochromocytoma and paraganglioma susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for gene-informed prevention. JAMA Oncol. 2017, 3:1204-12. 10.1001\/jamaoncol.2017.0223","journal-title":"JAMA Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0623","article-title":"Non-pheochromocytoma (PCC)\/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis","volume":"170","author":"Papathomas TG","year":"2014","unstructured":"Papathomas TG, Gaal J, Corssmit EP, et al.. Non-pheochromocytoma (PCC)\/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis. Eur J Endocrinol. 2014, 170:1-12. 10.1530\/EJE-13-0623","journal-title":"Eur J Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0033","article-title":"European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma","volume":"174","author":"Plouin PF","year":"2016","unstructured":"Plouin PF, Amar L, Dekkers OM, et al.. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol. 2016, 174:G1-G10. 10.1530\/EJE-16-0033","journal-title":"Eur J Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/77385-hereditary-pheochromocytoma-with-a-mutation-in-the-succinate-dehydrogenase-subunit-a-gene","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:39Z","timestamp":1707507519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/77385-hereditary-pheochromocytoma-with-a-mutation-in-the-succinate-dehydrogenase-subunit-a-gene"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.24584","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,29]]}}}